Among patients with DM, 80.07% (18/22; 95% CI: 24.49–100.0%) required insulin therapy, while 19.93% (4/22; 95% CI: 0.0–75.51%) were managed with oral hypoglycemic agents (Supplementary Figure S2). The gene discussed is INS; the disease is diabetes mellitus.